Fed. Circ. Weighs Undoing $24M Verdict In DNA IP Row
A Federal Circuit panel grappled Friday with whether prosecution history estoppel should have barred Bio-Rad Laboratories Inc. from invoking the doctrine of equivalents in its $23.9 million win last year against...To view the full article, register now.
Already a subscriber? Click here to view full article